The transgenic plant-produced recombinant CTB-IL-13 protein is currently being used for a GM1
ELISA binding assay to determine if it can efficiently bind to mucosal receptors.
Transgenic plant feeding trials will also be conducted to determine if they are effective in treating T1D. |